As expected, The Drug Enforcement Administration (DEA) published a new regulation on November 19, 2024, that temporarily extends the COVID-era flexibilities for prescribing controlled substances via telemedicine...
The Drug Enforcement Administration (DEA) announced a second extension of the temporary Covid-era exceptions to the Ryan Haight Act requirements for prescribing controlled substances.